WSFS
COGT icon

Wilmington Savings Fund Society’s Cogent Biosciences COGT Stock Holding History

Wilmington Savings Fund Society’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$14.6K Hold
380
– – ﹤0.01% 1133
2025
Q4 		$13.5K Sell
380
-350
-48% -$9.84K ﹤0.01% 1139
2025
Q3 		$10.5K Hold
730
– – ﹤0.01% 1163
2025
Q2 		$5.24K Hold
730
– – ﹤0.01% 1757
2025
Q1 		$4.37K Hold
730
– – ﹤0.01% 1800
2024
Q4 		$5.69K Hold
730
– – ﹤0.01% 1783
2024
Q3 		$7.88K Buy
+730
New +$7.11K ﹤0.01% 1680

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Wilmington Savings Fund Society's COGT Position: Q1 2026 in Review

Wilmington Savings Fund Society held its Cogent Biosciences (COGT) position steady in Q1 2026 at 380 shares worth $14.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1133.

Wilmington Savings Fund Society first reported a position in COGT in Q3 2024 and has held it in 7 quarters since. 305 funds tracked by Wall St. Rank hold COGT as of Q1 2026.

  • Wilmington Savings Fund Society held 380 shares of Cogent Biosciences worth $14.6K as of Q1 2026.
  • Wilmington Savings Fund Society left its Cogent Biosciences share count unchanged in Q1 2026.
  • Cogent Biosciences made up ﹤0.01% of Wilmington Savings Fund Society's portfolio in Q1 2026, its #1133 holding.
  • Wilmington Savings Fund Society first reported a position in Cogent Biosciences in Q3 2024 and has held it in 7 quarters since.
  • 305 funds tracked by Wall St. Rank held Cogent Biosciences as of Q1 2026.

Based on Wilmington Savings Fund Society's 13F filing for Q1 2026, filed 30 Apr 2026.